Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DINURU

Financiado

Cerrado

The Synthesis and Evaluation of Organometallic Dinuclear Ruthenium Complexes as...

The Synthesis and Evaluation of Organometallic Dinuclear Ruthenium Complexes as Anti Cancer Drugs "Current platinum-based anti-cancer drugs, such as cisplatin, are well established in the successful treatment of various forms of cancer, however, the use of these drugs is significantly limited by associated side effects and dru... ver más

30/06/2013

EPFL

179K€

Presupuesto del proyecto: 179K€

Líder del proyecto

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2013-06-30 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

EPFL

0.00€ | Lider

Proyectos interesantes

Organomet

Medical Technol...

Materials Scien...

157K€ Cerrado

CTQ2014-58812-C2-1-R

Medical Technol...

Chemical Engine...

85K€ Cerrado

RuCoPOC

Medical Technol...

Materials Scien...

150K€ Cerrado

CYTOTOXICTISALANS

Medical Technol...

Materials Scien...

168K€ Cerrado

STOADA

Medical Technol...

Materials Scien...

189K€ Cerrado

MET-EFFECT

Medical Technol...

Materials Scien...

764K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 179K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Current platinum-based anti-cancer drugs, such as cisplatin, are well established in the successful treatment of various forms of cancer, however, the use of these drugs is significantly limited by associated side effects and drug resistance. Ruthenium-based alternatives, some of which are in clinical testing, have shown considerable promise, exhibiting low general toxicity alongside selectivity and high activity toward cancerous tissue. This proposal takes advantage of these remarkable properties in the design, synthesis and evaluation of novel dinuclear ruthenium-based anti-cancer drugs. These complexes will contain two ruthenium moieties linked by an organic tether – the structure of which will have a major influence on the conformation of the complexes and will therefore influence their interactions with biomolecular targets. The relationship between complex structures and their anti-cancer properties will be studied and their biomolecular targets identified, allowing the rational development of more potent anti-cancer drugs that express their activity by non-DNA damaging modes of action – essential in overcoming the toxicity and resistance problems of established metal complexes. To achieve these objectives the candidate will build upon his experience in synthetic and analytical chemistry to isolate and characterize the complexes; he will develop expertise in bio-analytical techniques to allow him to identify their biomolecular targets and evaluate complex-biomolecule interactions/reactivity to probe their biological mode of anti-cancer activity. Through this project the candidate will gain substantial new expertise in biochemistry, proteomics and advanced mass spectrometry. He will gain experience in the management and coordination of an independent project whilst developing scientific and complementary skills, such as leadership qualities and teaching skills - essential in his development as a promising independent researcher."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores